Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 107.50
+3.00 (2.87%)
At close: Jul 9, 2026
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 167.31 billion as of July 9, 2026. Its market cap has increased by 10.42% in one year.
Market Cap
167.31B
Enterprise Value
162.42B
Revenue
38.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
107.50
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 167.31B, an increase of 2,002.30%. That is a compound annual growth rate of 136.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 167.31B | -30.36% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 59.61B |
| Lin BioScience | 47.13B |
| Oneness Biotech | 26.70B |
| CHO Pharma | 23.22B |
| Sunmax Biotechnology | 21.05B |
| TaiMed Biologics | 19.83B |
| Ever Supreme Bio Technology | 18.06B |
| Lumosa Therapeutics | 17.00B |